Ligand · GV9
GV9 · 3-(acetylamino)thiophene-2-carboxylic acid
GV9, 3-(acetylamino)thiophene-2-carboxylic acid (C7 H7 N O3 S, 185.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (2 PDB entries). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- GV9
- Formula
- C7 H7 N O3 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
GV9 in 2 structures; the first of them:
- 3GV9 · AmpC beta-lactamase in complex with Fragment-based Inhibitor · GV9 A1 · binds SER64, LEU119, GLN120, ASN152, TYR221, ASN289, LEU293, THR316 and 2 more
- 8AKC · Human Sirt6 in complex with ADP-ribose and fragment 3-(acetylamino)thiophene-2-carboxylic… · GV9 A408 · binds ILE61, PRO62, PHE64, VAL70, PHE82, PHE86, VAL115, MET136 and 1 more
Residues it binds most
LEU 3, PHE 2, GLY 4, VAL 3, ASN 2, MET 2, SER 3, ALA 3, LYS 2, PRO 3 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.